RxDoctor Payments Data

Zachary Haulsee, MD

Internal Medicine · Winston Salem, NCNPI 1225418239

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,326 and has fallen 54.1% since, to $609 in 2025. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,785in general payments, 2019–2025

Across 336 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • AbbVie$953
  • Novartis$792
  • Johnson & Johnson$598
  • AstraZeneca$472
  • Merck$322
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$5,785100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,785 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina →

Medicare billing

Part B allowed, 2024
$64,038
Medicare patients
196
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$608
Olanzapine13$519
Cefpodoxime Proxetil11$236
Pantoprazole Sodium31$227
Cefdinir17$177
Gabapentin15$161
Metoprolol Succinate27$147
Hydralazine Hcl11$146
Carvedilol15$140
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$101
Furosemide34$92
Ondansetron Hcl12$91
Isosorbide Mononitrate ErIsosorbide Mononitrate15$80
Amiodarone Hcl11$78
Oxycodone Hcl11$72

Paid to pharmacies, not to this prescriber.

Other internal medicine in Winston Salem

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →